메뉴 건너뛰기




Volumn 48, Issue 2, 2008, Pages 472-477

Superficial femoral artery thrombosis as a cause for distal embolism in primary antiphospholipid syndrome

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; FONDAPARINUX; HEPARIN; WARFARIN;

EID: 47249136169     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.02.052     Document Type: Article
Times cited : (6)

References (32)
  • 1
    • 33344458573 scopus 로고    scopus 로고
    • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
    • Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 (2006) 295-306
    • (2006) J Thromb Haemost , vol.4 , pp. 295-306
    • Miyakis, S.1    Lockshin, M.D.2    Atsumi, T.3    Branch, D.W.4    Brey, R.L.5    Cervera, R.6
  • 3
    • 0034884321 scopus 로고    scopus 로고
    • beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the Honolulu heart program
    • Brey R.L., Abbott R.D., Curb J.D., Sharp D.S., Ross G.W., Stallworth C.L., et al. beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the Honolulu heart program. Stroke 32 (2001) 1701-1706
    • (2001) Stroke , vol.32 , pp. 1701-1706
    • Brey, R.L.1    Abbott, R.D.2    Curb, J.D.3    Sharp, D.S.4    Ross, G.W.5    Stallworth, C.L.6
  • 5
    • 0031033493 scopus 로고    scopus 로고
    • Antiphospholipid syndrome: patterns of life threatening and severe recurrent vascular complications
    • Insko E.K., and Haskal Z.J. Antiphospholipid syndrome: patterns of life threatening and severe recurrent vascular complications. Radiology 202 (1997) 319-326
    • (1997) Radiology , vol.202 , pp. 319-326
    • Insko, E.K.1    Haskal, Z.J.2
  • 6
    • 13244292209 scopus 로고    scopus 로고
    • Proposals for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies
    • Reber G., Tincani A., Sanmarco M., de Moerloose P., and Boffa M.C. Proposals for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2 (2004) 1860-1862
    • (2004) J Thromb Haemost , vol.2 , pp. 1860-1862
    • Reber, G.1    Tincani, A.2    Sanmarco, M.3    de Moerloose, P.4    Boffa, M.C.5
  • 7
    • 0034903945 scopus 로고    scopus 로고
    • Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations-a cooperative project of the European Antiphospholipid Forum
    • Tincani A., Allegri F., Sanmarco M., Cinquini M., Taglietti M., Balsetrieri G., et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations-a cooperative project of the European Antiphospholipid Forum. Thromb Haemost 86 (2001) 575-583
    • (2001) Thromb Haemost , vol.86 , pp. 575-583
    • Tincani, A.1    Allegri, F.2    Sanmarco, M.3    Cinquini, M.4    Taglietti, M.5    Balsetrieri, G.6
  • 8
    • 0036228886 scopus 로고    scopus 로고
    • Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
    • Cervera R., Piette J.C., Font J., Khamashta M.A., Shoenfeld Y., Camps M.T., et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46 (2002) 1019-1027
    • (2002) Arthritis Rheum , vol.46 , pp. 1019-1027
    • Cervera, R.1    Piette, J.C.2    Font, J.3    Khamashta, M.A.4    Shoenfeld, Y.5    Camps, M.T.6
  • 9
    • 0141791073 scopus 로고    scopus 로고
    • A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome
    • Crowther M.A., Ginsberg J.S., Julian J., Math M., Denburg J., Hirsh J., et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 349 (2003) 1133-1138
    • (2003) N Engl J Med , vol.349 , pp. 1133-1138
    • Crowther, M.A.1    Ginsberg, J.S.2    Julian, J.3    Math, M.4    Denburg, J.5    Hirsh, J.6
  • 10
    • 33644606069 scopus 로고    scopus 로고
    • Management of antiphospholipid antibody syndrome: a systematic review
    • Lim W., Crowther M.A., and Eikelboom J.W. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 295 (2006) 1050-1057
    • (2006) JAMA , vol.295 , pp. 1050-1057
    • Lim, W.1    Crowther, M.A.2    Eikelboom, J.W.3
  • 11
    • 33644867063 scopus 로고    scopus 로고
    • Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention
    • Sacco R.L., Adams R., Albers G., Alberts M.J., Benavente O., Furie K., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention. Stroke 37 (2006) 577-617
    • (2006) Stroke , vol.37 , pp. 577-617
    • Sacco, R.L.1    Adams, R.2    Albers, G.3    Alberts, M.J.4    Benavente, O.5    Furie, K.6
  • 12
    • 33745225893 scopus 로고    scopus 로고
    • Use of fondaparinux in a patient with antiphospholipid antibody syndrome and heparin-associated thrombocytopenia
    • Holton S.G., Knox S.K., and Tefferi A. Use of fondaparinux in a patient with antiphospholipid antibody syndrome and heparin-associated thrombocytopenia. J Thromb Haemost 4 (2006) 1632-1634
    • (2006) J Thromb Haemost , vol.4 , pp. 1632-1634
    • Holton, S.G.1    Knox, S.K.2    Tefferi, A.3
  • 13
    • 1542645757 scopus 로고    scopus 로고
    • Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins
    • Parody R., Olive A., Souto J.C., and Fontcuberta J. Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins. Haematologica 88 (2003) ECR32
    • (2003) Haematologica , vol.88
    • Parody, R.1    Olive, A.2    Souto, J.C.3    Fontcuberta, J.4
  • 14
    • 18844385757 scopus 로고    scopus 로고
    • Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux
    • Kovacs M.J. Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux. Thromb Haemost 93 (2005) 999-1000
    • (2005) Thromb Haemost , vol.93 , pp. 999-1000
    • Kovacs, M.J.1
  • 15
    • 2542554965 scopus 로고    scopus 로고
    • Antiphospholipid syndrome: multiple mechanisms
    • Mackworth-Young C.G. Antiphospholipid syndrome: multiple mechanisms. Clin Exp Immunol 136 (2004) 393-401
    • (2004) Clin Exp Immunol , vol.136 , pp. 393-401
    • Mackworth-Young, C.G.1
  • 16
    • 33846243719 scopus 로고    scopus 로고
    • Current concepts on the pathogenesis of the antiphospholipid syndrome
    • Giannakopoulos B., Passam F., Rahgozar S., and Krilis S. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 109 (2007) 422-430
    • (2007) Blood , vol.109 , pp. 422-430
    • Giannakopoulos, B.1    Passam, F.2    Rahgozar, S.3    Krilis, S.4
  • 17
    • 34547471144 scopus 로고    scopus 로고
    • Endothelial dysfunction in patients with antiphospholipid syndrome assessed with positron emission tomography
    • Alexanderson E., Cruz P., Vargas A., Meave A., Ricalde A., Talayero J.A., et al. Endothelial dysfunction in patients with antiphospholipid syndrome assessed with positron emission tomography. J Nucl Cardiol 14 (2007) 566-572
    • (2007) J Nucl Cardiol , vol.14 , pp. 566-572
    • Alexanderson, E.1    Cruz, P.2    Vargas, A.3    Meave, A.4    Ricalde, A.5    Talayero, J.A.6
  • 18
    • 37749045374 scopus 로고    scopus 로고
    • Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies
    • Jy W., Tiede M., Bidot C.J., Horstman L.L., Jimenez J.J., Chirinos J., et al. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies. Thromb Res 121 (2007) 319-325
    • (2007) Thromb Res , vol.121 , pp. 319-325
    • Jy, W.1    Tiede, M.2    Bidot, C.J.3    Horstman, L.L.4    Jimenez, J.J.5    Chirinos, J.6
  • 19
    • 34447312169 scopus 로고    scopus 로고
    • Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome
    • Christodoulou C., Sangle S., and D'Cruz D.P. Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome. Rheum 46 (2007) 907-910
    • (2007) Rheum , vol.46 , pp. 907-910
    • Christodoulou, C.1    Sangle, S.2    D'Cruz, D.P.3
  • 20
    • 32644443487 scopus 로고    scopus 로고
    • Accelerated atherosclerosis in autoimmune rheumatic diseases
    • Shoenfeld Y., Gerli R., Doria A., Matsuura E., Cerinic M.M., Ronda N., et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circ 112 (2005) 3337-3347
    • (2005) Circ , vol.112 , pp. 3337-3347
    • Shoenfeld, Y.1    Gerli, R.2    Doria, A.3    Matsuura, E.4    Cerinic, M.M.5    Ronda, N.6
  • 21
    • 7044262101 scopus 로고    scopus 로고
    • Peripheral vascular disease in antiphospholipid syndrome
    • Vlachoyiannopoulos P.G., and Samarkos M. Peripheral vascular disease in antiphospholipid syndrome. Thromb Res 114 (2004) 509-519
    • (2004) Thromb Res , vol.114 , pp. 509-519
    • Vlachoyiannopoulos, P.G.1    Samarkos, M.2
  • 22
    • 34547407889 scopus 로고    scopus 로고
    • Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals
    • Erkan D., Harrison M.J., Levy R., Peterson M., Petri M., Sammaritano L., et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum 56 (2007) 2382-2391
    • (2007) Arthritis Rheum , vol.56 , pp. 2382-2391
    • Erkan, D.1    Harrison, M.J.2    Levy, R.3    Peterson, M.4    Petri, M.5    Sammaritano, L.6
  • 23
    • 0141791073 scopus 로고    scopus 로고
    • A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome
    • Crowther M.A., Ginsberg J.S., Julian J., Denburg J., Hirsh J., Douketis J., et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 349 (2003) 1133-1138
    • (2003) N Engl J Med , vol.349 , pp. 1133-1138
    • Crowther, M.A.1    Ginsberg, J.S.2    Julian, J.3    Denburg, J.4    Hirsh, J.5    Douketis, J.6
  • 24
    • 23844437705 scopus 로고    scopus 로고
    • A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)
    • Finazzi G., Marchioli R., Brancaccio V., Schinoco P., Wisloff F., Musial J., et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost 5 (2005) 848-853
    • (2005) J Thromb Haemost , vol.5 , pp. 848-853
    • Finazzi, G.1    Marchioli, R.2    Brancaccio, V.3    Schinoco, P.4    Wisloff, F.5    Musial, J.6
  • 25
    • 10044247363 scopus 로고    scopus 로고
    • Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study
    • Zavaleta N.E., Montes R.M., Soto M.E., Vanzzini N.A., and Amigo M.C. Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study. J Rheumatol 31 (2004) 2402-2407
    • (2004) J Rheumatol , vol.31 , pp. 2402-2407
    • Zavaleta, N.E.1    Montes, R.M.2    Soto, M.E.3    Vanzzini, N.A.4    Amigo, M.C.5
  • 27
    • 34948874137 scopus 로고    scopus 로고
    • Peripheral vascular occlusions leading to gangrene and amputations in antiphospholipid antibody positive patients
    • Asherson R.A., Cervera R., and Shoenfeld Y. Peripheral vascular occlusions leading to gangrene and amputations in antiphospholipid antibody positive patients. Ann N Y Acad Sci 1108 (2007) 515-529
    • (2007) Ann N Y Acad Sci , vol.1108 , pp. 515-529
    • Asherson, R.A.1    Cervera, R.2    Shoenfeld, Y.3
  • 28
    • 0026510726 scopus 로고
    • Vascular disease in the antiphospholipid syndrome: a comparison with the patient population with atherosclerosis
    • Shortell C.K., Ouriel K., Green R.M., Condemi J.J., and DeWeese J.A. Vascular disease in the antiphospholipid syndrome: a comparison with the patient population with atherosclerosis. J Vasc Surg 15 (1992) 158-166
    • (1992) J Vasc Surg , vol.15 , pp. 158-166
    • Shortell, C.K.1    Ouriel, K.2    Green, R.M.3    Condemi, J.J.4    DeWeese, J.A.5
  • 29
    • 0027941944 scopus 로고
    • Primary antiphospholipid syndrome in a child with lower extremity arterial thrombosis
    • Jicha D.L., Caty M.G., and Lillehei C.W. Primary antiphospholipid syndrome in a child with lower extremity arterial thrombosis. J Ped Surg 29 (1994) 1519-1520
    • (1994) J Ped Surg , vol.29 , pp. 1519-1520
    • Jicha, D.L.1    Caty, M.G.2    Lillehei, C.W.3
  • 30
    • 0023952062 scopus 로고
    • Postoperative thrombotic complications in patients with the lupus anticoagulant: Increased risk after vascular procedures
    • Ahn S.S., Kalunian K., Rosove M., and Moore W.S. Postoperative thrombotic complications in patients with the lupus anticoagulant: Increased risk after vascular procedures. J Vasc Surg 7 (1988) 749-756
    • (1988) J Vasc Surg , vol.7 , pp. 749-756
    • Ahn, S.S.1    Kalunian, K.2    Rosove, M.3    Moore, W.S.4
  • 31
    • 0029964786 scopus 로고    scopus 로고
    • Prospective comparison of infrainguinal bypass grafting in patients with and without antiphospholipid antibodies
    • Lee R.W., Taylor Jr. L.M., Landry G.J., Goodnight S.H., Moneta G.L., Edwards J.M., et al. Prospective comparison of infrainguinal bypass grafting in patients with and without antiphospholipid antibodies. J Vasc Surg 24 (1996) 524-531
    • (1996) J Vasc Surg , vol.24 , pp. 524-531
    • Lee, R.W.1    Taylor Jr., L.M.2    Landry, G.J.3    Goodnight, S.H.4    Moneta, G.L.5    Edwards, J.M.6
  • 32
    • 0035347253 scopus 로고    scopus 로고
    • Relationship between antiphospholipid antibodies and progression of lower extremity arterial occlusive disease after lower extremity bypass operations
    • Lam E.Y., Taylor Jr. L.M., Landry G.J., Porter J.M., and Moneta G.L. Relationship between antiphospholipid antibodies and progression of lower extremity arterial occlusive disease after lower extremity bypass operations. J Vasc Surg 33 (2001) 976-982
    • (2001) J Vasc Surg , vol.33 , pp. 976-982
    • Lam, E.Y.1    Taylor Jr., L.M.2    Landry, G.J.3    Porter, J.M.4    Moneta, G.L.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.